洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2100047181】Total thyroidectomy versus Total thyroidectomy with prophylactic central compartment neck dissection in early papillary thyroid cancer

基本信息
登记号

ChiCTR2100047181

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-06-10

临床申请受理号

/

靶点

/

适应症

thyroid cancer

试验通俗题目

Total thyroidectomy versus Total thyroidectomy with prophylactic central compartment neck dissection in early papillary thyroid cancer

试验专业题目

Total thyroidectomy versus Total thyroidectomy with prophylactic central compartment neck dissection in early papillary thyroid cancer

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

The main objective of the current study is to make a comparison between total thyroidectomy with prophylactic central compartment neck dissection and that without it. It specifically relates to papillary thyroid cancer with clinically negative cervical LN metastasis. The study mainly concentrates on the complications rate and the risk of recurrence of the disease.

试验分类
请登录查看
试验类型

非随机对照试验

试验分期

其它

随机化

非随机对照试验

盲法

N/A

试验项目经费来源

no fund

试验范围

/

目标入组人数

40

实际入组人数

/

第一例入组时间

2017-06-09

试验终止时间

2017-11-09

是否属于一致性

/

入选标准

Cases with early thyroid cancer of the papillary type (T1, T2 N0 M0), previously diagnosed with FNAC or histopathological surprise in patients who underwent complete thyroidectomy.;

排除标准

1.Papillary thyroid tumor but unfit for operation, associated with metastasis, associated with clinically positive cervical LNs (central or lateral). 2.Recurrent papillary thyroid tumor, with or without previous thyroid operation. 3.Locally advanced papillary thyroid cancer (T3, T4). 4.Micro papillary thyroid cancer.;

研究者信息
研究负责人姓名
请登录查看
试验机构

self sponsored

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用